World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
19605
World Ranking
18505
National Ranking
9222

Fabio Pellegrini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fabio Pellegrini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 271 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Fabio Pellegrini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fabio Pellegrini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Fabio Pellegrini is affiliated with Biogen in the United States, focusing on research at the intersection of medicine and mathematics. Their work has a strong emphasis on multiple sclerosis (MS) research studies, as well as advanced statistical methods and causal inference techniques. Pellegrini's research spans several fields, including medicine, statistics and probability, pathology and forensic medicine, economics and econometrics, molecular biology, and rheumatology.

Pellegrini has contributed extensively to studies on health systems, economic evaluations, and quality of life, as well as topics related to statistical methods in clinical trials and mental health research. Their publications also cover areas such as bioinformatics and genomic networks, reflecting a multidisciplinary approach to biomedical research.

Their recent publications include:

  • Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS), 2020, Frontiers in Neurology
  • Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network, 2021, Multiple Sclerosis Journal
  • Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network, 2021, Frontiers in Neurology
  • Recommendations for the use of propensity score methods in multiple sclerosis research, 2022, Multiple Sclerosis Journal
  • A two-stage prediction model for heterogeneous effects of treatments, 2021, Statistics in Medicine

Pellegrini frequently publishes in venues such as arXiv (Cornell University), Frontiers in Neurology, Multiple Sclerosis Journal, Statistics in Medicine, and Research Synthesis Methods. These venues highlight the focus on both clinical and methodological aspects of medical research, particularly relating to MS and biostatistics.

Frequent co-authors working closely with Pellegrini include Carl de Moor, Gabrielle Simoneau, Konstantina Chalkou, Georgia Salanti, and Andrea Manca. This network of collaborators reflects interdisciplinary teamwork combining expertise in statistics, medical research, and health economics.

Their work includes substantial contributions to the development and application of advanced causal inference techniques, with a focus on improving decision-making in clinical research. These efforts are particularly visible in studies addressing treatment effects and outcomes in neurological conditions such as multiple sclerosis.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease: A Systematic Review and Meta-analysis

    Suetonia C. Palmer;Andrew Hayen;Petra Macaskill;Fabio Pellegrini

  • Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies

    Suetonia Palmer;Mariacristina Vecchio;Jonathan C. Craig;Marcello Tonelli

  • CARMELA: Assessment of Cardiovascular Risk in Seven Latin American Cities

    Herman Schargrodsky;Rafael Hernández-Hernández;Beatriz Marcet Champagne;Honorio Silva

  • Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    P. Knoebl;P. Marco;F. Baudo;Peter William Collins

  • Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

    Giorgia De Berardis;Michele Sacco;Giovanni F M Strippoli;Fabio Pellegrini

  • Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

    Giovanni F M Strippoli;Sankar D Navaneethan;David W Johnson;Vlado Perkovic

  • Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

    Monica Franciosi;Giuseppe Lucisano;Emanuela Lapice;Giovanni F. M. Strippoli

  • Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients Results of the Primary Prevention Project (PPP) trial

    Michele Sacco;Fabio Pellegrini;Maria C. Roncaglioni;Fausto Avanzini

  • Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

    Suetonia C. Palmer;Sankar D. Navaneethan;Jonathan C. Craig;David W. Johnson

  • Course and prognosis in early-onset MS Comparison with adult-onset forms

    I. L. Simone;D. Carrara;C. Tortorella;M. Liguori

  • The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies.

    Monica Franciosi;Fabio Pellegrini;Giorgia De Berardis;Maurizio Belfiglio

  • Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked.

    Giorgia De Berardis;Monica Franciosi;Maurizio Belfiglio;Barbara Di Nardo

  • Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

    Francesco Baudo;Peter William Collins;Angela Huth-Kuhne;Herve Levesque

  • Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.

    Suetonia C. Palmer;Jonathan C. Craig;Sankar D. Navaneethan;Marcello Tonelli

  • Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)

    Peter William Collins;Francesco Baudo;Paul Knoebl;Herve Levesque

  • New natural history of interferon‐β–treated relapsing multiple sclerosis

    Maria Trojano;Fabio Pellegrini;Aurora Fuiani;Damiano Paolicelli

  • Association of aspirin use with major bleeding in patients with and without diabetes.

    Giorgia De Berardis;Giuseppe Lucisano;Antonio D’Ettorre;Fabio Pellegrini

  • Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis

    Suetonia C Palmer;Lucia Di Micco;Mona Razavian;Jonathan C Craig

  • Clinical application of transthoracic ultrasonography in inpatients with pneumonia

    Marco Sperandeo;Vincenzo Carnevale;Silvana Muscarella;Giuseppe Sperandeo

Frequent Co-Authors

Antonio Nicolucci
Antonio Nicolucci Mario Negri Institute for Pharmacological Research
Giovanni F.M. Strippoli
Giovanni F.M. Strippoli University of Sydney
Jonathan C. Craig
Jonathan C. Craig Flinders University
Gianni Tognoni
Gianni Tognoni University of Milan
Maria Trojano
Maria Trojano University of Bari Aldo Moro
Suetonia C. Palmer
Suetonia C. Palmer University of Otago
Helmut Butzkueven
Helmut Butzkueven Monash University
Vito Michele Fazio
Vito Michele Fazio Università Campus Bio-Medico
Sheldon Greenfield
Sheldon Greenfield University of California, Irvine
Marcello Tonelli
Marcello Tonelli University of Calgary

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens doors to numerous online degrees and career pathways in healthcare. For those interested in healthcare, but not traditional medical school, there are many flexible online programs to consider. For example, those looking for administrative roles in healthcare can explore healthcare administration degrees, which prepare students for leadership and management positions in hospitals and clinics.

If you want a fast entry into the medical field, starting with certification programs can be a great choice. You might consider using financial aid for medical billing and coding to help support your studies in an area with strong job demand.

For those pursuing nursing, there are options to become a Licensed Practical Nurse through an lpn program without teas test requirements, making the process more accessible. Registered nurses aiming for advanced practice roles can look into an rn to np bridge program, which enables career progression to nurse practitioner efficiently.

These online pathways offer flexibility, expedited learning, and financial support—allowing you to pursue a rewarding career in healthcare from almost anywhere.

Best Scientists Citing Fabio Pellegrini

Trending Scientists

Recently Published Articles